168 related articles for article (PubMed ID: 37263570)
1. Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19.
Menez S; Coca SG; Moledina DG; Wen Y; Chan L; Thiessen-Philbrook H; Obeid W; Garibaldi BT; Azeloglu EU; Ugwuowo U; Sperati CJ; Arend LJ; Rosenberg AZ; Kaushal M; Jain S; Wilson FP; Parikh CR;
Am J Kidney Dis; 2023 Sep; 82(3):322-332.e1. PubMed ID: 37263570
[TBL] [Abstract][Full Text] [Related]
2. Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Coca SG; Vasquez-Rios G; Mansour SG; Moledina DG; Thiessen-Philbrook H; Wurfel MM; Bhatraju P; Himmelfarb J; Siew E; Garg AX; Hsu CY; Liu KD; Kimmel PL; Chinchilli VM; Kaufman JS; Wilson M; Banks RE; Packington R; McCole E; Kurth MJ; Richardson C; Go AS; Selby NM; Parikh CR
Am J Kidney Dis; 2023 Feb; 81(2):190-200. PubMed ID: 36108888
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19.
Menez S; Moledina DG; Thiessen-Philbrook H; Wilson FP; Obeid W; Simonov M; Yamamoto Y; Corona-Villalobos CP; Chang C; Garibaldi BT; Clarke W; Farhadian S; Dela Cruz C; Coca SG; Parikh CR;
Am J Kidney Dis; 2022 Feb; 79(2):257-267.e1. PubMed ID: 34710516
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative kidney biomarkers and risks for death, cardiovascular and chronic kidney disease events after cardiac surgery: the TRIBE-AKI study.
Vasquez-Rios G; Moledina DG; Jia Y; McArthur E; Mansour SG; Thiessen-Philbrook H; Shlipak MG; Koyner JL; Garg AX; Parikh CR; Coca SG;
J Cardiothorac Surg; 2022 Dec; 17(1):338. PubMed ID: 36567329
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
Wilson M; Packington R; Sewell H; Bartle R; McCole E; Kurth MJ; Richardson C; Shaw S; Akani A; Banks RE; Selby NM
Am J Kidney Dis; 2022 May; 79(5):646-656.e1. PubMed ID: 34653541
[TBL] [Abstract][Full Text] [Related]
6. Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.
Neirynck N; Glorieux G; Schepers E; Verbeke F; Vanholder R
PLoS One; 2015; 10(3):e0122073. PubMed ID: 25823004
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Blood and Urine Biomarkers to Identify Acute Kidney Injury Subphenotypes and Associations With Long-term Outcomes.
Bhatraju PK; Prince DK; Mansour S; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Kaufman JS; Kimmel PL; Coca SG; Parikh CR; Wurfel MM; Himmelfarb J
Am J Kidney Dis; 2023 Sep; 82(3):311-321.e1. PubMed ID: 37178093
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension.
Chen TK; Estrella MM; Appel LJ; Coresh J; Luo S; Reiser J; Obeid W; Parikh CR; Grams ME
Am J Kidney Dis; 2021 Jul; 78(1):75-84.e1. PubMed ID: 33388403
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
Neyra JA; Ortiz-Soriano V; Liu LJ; Smith TD; Li X; Xie D; Adams-Huet B; Moe OW; Toto RD; Chen J
Am J Kidney Dis; 2023 Jan; 81(1):36-47. PubMed ID: 35868537
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology.
Arikan H; Ozturk S; Tokgoz B; Dursun B; Seyahi N; Trabulus S; Islam M; Ayar Y; Gorgulu N; Karadag S; Gok M; Akcali E; Bora F; Aydın Z; Altun E; Ahbap E; Polat M; Soypacacı Z; Oguz EG; Koyuncu S; Colak H; Sahin İ; Dolarslan ME; Helvacı O; Kurultak I; Eren Z; Dheir H; Ogutmen MB; Taymez DG; Genek DG; Ozkurt S; Bakır EA; Yuksel E; Sahutoglu T; Oto OA; Boz G; Sengul E; Kara E; Tuglular S
PLoS One; 2021; 16(8):e0256023. PubMed ID: 34375366
[TBL] [Abstract][Full Text] [Related]
11. Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.
Ng JH; Hirsch JS; Hazzan A; Wanchoo R; Shah HH; Malieckal DA; Ross DW; Sharma P; Sakhiya V; Fishbane S; Jhaveri KD;
Am J Kidney Dis; 2021 Feb; 77(2):204-215.e1. PubMed ID: 32961245
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-Associated Acute Kidney Injury and Longitudinal Kidney Outcomes.
Aklilu AM; Kumar S; Nugent J; Yamamoto Y; Coronel-Moreno C; Kadhim B; Faulkner SC; O'Connor KD; Yasmin F; Greenberg JH; Moledina DG; Testani JM; Wilson FP
JAMA Intern Med; 2024 Apr; 184(4):414-423. PubMed ID: 38407862
[TBL] [Abstract][Full Text] [Related]
13. Association of an Acute Kidney Injury Follow-up Clinic With Patient Outcomes and Care Processes: A Cohort Study.
Silver SA; Adhikari NK; Jeyakumar N; Luo B; Harel Z; Dixon SN; Brimble KS; Clark EG; Neyra JA; Vijayaraghavan BKT; Garg AX; Bell CM; Wald R
Am J Kidney Dis; 2023 May; 81(5):554-563.e1. PubMed ID: 36521779
[TBL] [Abstract][Full Text] [Related]
14. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
15. Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events.
Cheng W; Wu X; Liu Q; Wang HS; Zhang NY; Xiao YQ; Yan P; Li XW; Duan XJ; Peng JC; Feng S; Duan SB
Eur Radiol; 2020 Jun; 30(6):3516-3527. PubMed ID: 32080754
[TBL] [Abstract][Full Text] [Related]
16. Processes of Care After Hospital Discharge for Survivors of Acute Kidney Injury: A Population-Based Cohort Study.
Brar S; Ye F; James MT; Harrison TG; Pannu N;
Am J Kidney Dis; 2024 Feb; 83(2):216-228. PubMed ID: 37734688
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Recurrent Acute Kidney Injury in a Large Population-Based Cohort.
Liu KD; Yang J; Tan TC; Glidden DV; Zheng S; Pravoverov L; Hsu CY; Go AS
Am J Kidney Dis; 2019 Feb; 73(2):163-173. PubMed ID: 30482577
[TBL] [Abstract][Full Text] [Related]
18. Dialysis requirement, long-term major adverse cardiovascular events (MACE) and all-cause mortality in hospital acquired acute kidney injury (AKI): a propensity-matched cohort study.
Omotoso BA; Abdel-Rahman EM; Xin W; Ma JZ; Scully KW; Arogundade FA; Balogun RA
J Nephrol; 2016 Dec; 29(6):847-855. PubMed ID: 27307250
[TBL] [Abstract][Full Text] [Related]
19. The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S; Wen Y; Xu L; Moledina DG; Thiessen-Philbrook H; Hu D; Obeid W; Bhatraju PK; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Liu KD; Kaufman JS; Kimmel PL; Himmelfarb J; Coca SG; Cantley LG; Parikh CR
Kidney Int; 2023 Dec; 104(6):1194-1205. PubMed ID: 37652206
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Impact of the COVID-19 Associated AKI: The Relationship between Kidney Recovery and Mortality in a 10-Month Follow-Up Cohort Study.
Hadadi A; Farrokhpour H; Rashedi S; Kafan S; Sotoudehnia M; Rahimzadeh H; Tabatabaei S; Razeghi E; Aghsaeifard Z
Kidney Blood Press Res; 2022; 47(7):486-491. PubMed ID: 35378541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
